Key result
Enzyme immunoassay testing reveals 26% HAV IgM prevalence in clinically suspected Hepatitis A cases.
Why the study?
What is the prevalence of Hepatitis A virus in clinically suspected patients at a tertiary care hospital in Vadodara?
Cross-Sectional (n=431)
No
What is the prevalence of Hepatitis A virus in clinically suspected patients at a tertiary care hospital in Vadodara?
Answers are grounded in this paper and cite their sources.
The study found a 26% prevalence of acute Hepatitis A infection among clinically suspected patients at a tertiary care center in Vadodara, India.
Background: The 27 nm, non-enveloped, single-stranded RNA Hepatitis A virus (HAV) belongs to the genus Hepatovirus and family Picornaviridae. The hepatitis A virus, which causes both sporadic and epidemic forms of acute hepatitis, is mostly transmitted through the fecal-oral route, which involves consuming tainted food and beverages. Material and methods: Over a period of 1 year from April 2024 to March 2025, a total of 431 blood samples from clinically suspected Hepatitis A patients were received in department of microbiology. Serum was separated and subjected to enzyme immunoassay for detection of HAV IgM Antibody (anti- HAV IgM). Results: During this study period, a total 431 blood samples were processed from suspected Hepatitis A cases out of which 112 (26%) samples were found to be positive for HAV IgM Antibody (anti- HAV IgM). Conclusion: HAV causes AVH most commonly in early childhood and a small number of adolescents and adults. Females are more commonly infected than males. The preventive strategies and control measures of hepatitis A will be determined by future definition of HAV epidemiology in the Central Karnataka region, India.
No takes yet. Share an insight, caveat, or question.
Muthukumaran et al. (2026) conducted a cross-sectional in Clinically suspected Hepatitis A (n=431). Enzyme immunoassay for HAV IgM Antibody was evaluated on HAV IgM Antibody positivity. Enzyme immunoassay testing of 431 clinically suspected Hepatitis A cases revealed a 26% prevalence of HAV IgM antibodies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: